Low-Grade Appendiceal Mucinous Neoplasm (LAMN)
LAMN is a rare appendiceal tumor characterized by mucinous epithelial proliferation with low-grade cytologic atypia that accounts for only 0.2-0.3% of all appendectomies, and while it appears benign when confined to the appendix, it carries significant long-term risk when the appendiceal wall is breached, potentially leading to pseudomyxoma peritonei with guarded prognosis. 1
Pathological Definition and Classification
LAMN is defined by a villous or flat proliferation of mucinous epithelium with low-grade atypia, distinguishing it from mucinous adenocarcinomas (MACA) which demonstrate destructive invasion, complex epithelial proliferations, or high-grade nuclear atypia 1. The critical pathological distinction is:
- LAMN: Low-grade cytologic atypia, mucin production, villous architecture
- MACA: High-grade atypia, destructive invasion, desmoplastic stromal response
- Discordant cases: LAMN in appendix but high-grade peritoneal disease (behave as adenocarcinoma) 1
Meticulous gross examination with complete embedding of the appendix is essential, as subtle macroscopic findings like wall discontinuities and mucinous exudate may herald clinically significant peritoneal dissemination 2.
Clinical Presentation
LAMN typically presents with symptoms indistinguishable from acute appendicitis—right lower quadrant pain, nausea, and abdominal distension 3, 4. Physical examination may reveal a palpable mass with tenderness and guarding in advanced cases 3. The diagnosis is most commonly made incidentally on histopathological examination after appendectomy for presumed acute appendicitis 5.
Imaging findings that should raise suspicion include cystic dilation of the appendix on ultrasound or CT, suggesting appendiceal mucocele rather than simple inflammation 2.
Prognosis Based on Disease Extent
The prognosis of LAMN is critically dependent on whether disease is confined to the appendix or has spread beyond:
LAMN Confined to Appendix
Tumors rigorously confirmed to be confined to the appendix are clinically benign with no recurrences observed in long-term follow-up (median 6 years) 1. This requires thorough pathological evaluation of the entire appendix.
LAMN with Extra-Appendiceal Spread
When the mucinous epithelium breaches the appendiceal wall, the long-term outlook becomes guarded:
- 3-year survival: 100%
- 5-year survival: 86%
- 10-year survival: 45% 1
This means just over half of patients die of disease after 10 years, even with low-grade histology. Recent data from 2026 shows recurrence rates of 31.8% and mortality of 20.5% in cohorts with advanced disease burden 6.
Pseudomyxoma Peritonei (PMP)
Approximately 58.8% of LAMN patients present with PMP at diagnosis 6. Peritoneal disease in LAMN consists of mucin pools harboring low-grade mucinous epithelium, usually dissecting in hyalinized stroma 1. The bulk of peritoneal disease correlates with worse prognosis 1.
Treatment Approach
Primary Surgical Management
For LAMN confined to the appendix, appendectomy alone is curative 1, 4.
For LAMN with peritoneal spread, cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is the primary treatment 7, 6. However, HIPEC utilization remains suboptimal—only 22.4% in one recent cohort—which likely contributes to higher recurrence rates 6.
Adjuvant Systemic Therapy
Adjuvant systemic treatment was used in 50% of patients in recent series and showed statistically significant correlation with reduced recurrence on univariate analysis (p=0.007) 6. This suggests a potential role, though optimal regimens remain undefined.
Surveillance and Follow-Up
There are no formal surveillance guidelines after appendectomy for LAMN 7. Postoperative surveillance is individualized according to tumor presentation, pathology, and treatment 7.
Imaging Modalities for Surveillance
CT abdomen and pelvis with IV contrast is the primary surveillance modality for peritoneal disease 7. However, CT has significant limitations:
- Sensitivity for small peritoneal nodules (<0.5 cm): only 11%
- Sensitivity for nodules >5 cm: 94%
- CT peritoneal cancer index (PCI) significantly underestimates intraoperative PCI (correlation 55-70%) 7
MRI with diffusion-weighted imaging (DWI) demonstrates superior performance for peritoneal disease detection 7:
- 100% sensitivity and specificity for liver metastases (vs. 87.5% and 95.5% for CT)
- Improved detection of extraperitoneal findings over CT
- Particularly valuable for patients treated with chemotherapy
Post-cytoreduction, CT or MRI of abdomen and pelvis appears appropriate for low-grade pseudomyxoma peritonei follow-up 7.
Essential Post-Operative Evaluation
Postoperative colonoscopy should be performed to evaluate the appendiceal orifice and exclude synchronous colorectal lesions 5.
Critical Clinical Pitfalls
Assuming benign behavior without complete pathological assessment: Even low-grade tumors can have extra-appendiceal spread with significant long-term mortality 1
Inadequate gross examination: Subtle wall discontinuities may be the only sign of peritoneal dissemination 2
Relying solely on CT for peritoneal disease assessment: CT significantly underestimates disease burden, particularly for small implants 7
Underutilization of HIPEC: Lower HIPEC rates correlate with higher recurrence and mortality 6
Failure to recognize discordant cases: LAMN in the appendix with high-grade peritoneal disease behaves as adenocarcinoma and requires aggressive management 1